Skip to main content
. 2020 Jul-Sep;24(3):245–249. doi: 10.5935/1518-0557.20200004

Table 1.

Characteristics of the studied population according to treatment and results obtained

Treatment rhFSH n=11 LH-rhFSH n=30 HMG-rhFSH n=10
Mean age (years) 34.7±3.1 (29-39) 38.1±3.2 (29-42) 38.7±2.0 (34-41)
Male factor 5 3 2
Tubal factor 1 10 1
Decreased ovarian reserve 1 0 0
Mixed 4 15 6
Idiopathic 0 2 1
No of Oocytes retrieved 6.9±3.8 (2-13) 5.1±3.7 (0-18) 5.4±2.9 (3-12)
No of Oocytes MII 4.7±2.2 (2-8) 3.2±2.4 (0-12) 2.9±2.2 (0-7)

rhFSH: recombinant human FSH;

rhFSH: rhFSH along with recombinant LH;

rhFSH: rhFSH plus human menopausal gonadotrophin: MII: metaphase II oocytes